Dec 14, 2020
1:25
For every 25 shares held, investors received 1. The price per share adjusted from $0.20 to $0.01.
The split itself did not change the total investment value.
BioInvent International AB (publ) (BOVNF) trades on the Other OTC in the Biotechnology industry.
BioInvent International AB (publ) company overviewThe latest split shown was on December 14, 2020. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
This history records 5 splits between November 24, 2014 and December 14, 2020.
Already premium?